A50.SI SES
Thomson Medical Group Limited
1W: -3.9%
1M: -5.7%
3M: -5.7%
YTD: -18.0%
1Y: +2.0%
3Y: -10.0%
5Y: -41.8%
S$0.05 ($0.04)
+0.00 (+2.00%)
Weekly Expected Move ±2.9%
S$0
S$0
S$0
S$0
S$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$1.8B
-1.4% ▼
5Y CAGR: +6.6%
Total Liabilities
$1.2B
+0.3% ▲
5Y CAGR: +10.8%
Shareholders Equity
$471M
-5.8% ▼
5Y CAGR: -0.3%
Cash & Investments
$124M
-25.7% ▼
5Y CAGR: -3.4%
Total Debt
$1.1B
+0.0% ▲
5Y CAGR: +11.1%
Net Debt
$997M
+4.5% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $71M | $162M | $287M | $167M | $124M |
| Short-Term Investments | $44M | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $115M | $162M | $287M | $167M | $124M |
| Net Receivables | $13M | $53M | $55M | $32M | $43M |
| Inventory | $101M | $99M | $92M | $106M | $139M |
| Other Current Assets | $21M | $4M | $3M | $3M | $4M |
| Total Current Assets | $250M | $321M | $441M | $317M | $320M |
| Property, Plant & Equip. | $446M | $457M | $431M | $489M | $499M |
| Goodwill & Intangibles | $487M | $484M | $482M | $897M | $825M |
| Long-Term Investments | $0 | $102M | $94M | $106M | $4M |
| Other Non-Current Assets | $102M | $0 | $0 | $0 | $137M |
| Total Non-Current Assets | $1.0B | $1.0B | $1.0B | $1.5B | $1.5B |
| Total Assets | $1.3B | $1.4B | $1.4B | $1.8B | $1.8B |
| — Liabilities — | |||||
| Accounts Payable | $10M | $13M | $13M | $15M | $18M |
| Short-Term Debt | $321K | $228M | $12M | $189M | $164M |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $37M | $46M | $46M | $46M | $42M |
| Total Current Liabilities | $83M | $339M | $120M | $292M | $269M |
| Long-Term Debt | $619M | $401M | $736M | $917M | $942M |
| Other Non-Current Liab. | $842K | $879K | $862K | $799K | $2M |
| Total Non-Current Liabilities | $636M | $418M | $752M | $940M | $967M |
| Total Liabilities | $720M | $757M | $872M | $1.2B | $1.2B |
| — Equity — | |||||
| Common Stock | $2.4B | $2.4B | $2.4B | $2.4B | $2.4B |
| Retained Earnings | $98M | $149M | $155M | $158M | $111M |
| Accumulated OCI | -$2.0B | -$2.0B | -$2.0B | -$2.0B | -$2.0B |
| Total Stockholders Equity | $490M | $532M | $499M | $500M | $471M |
| Total Liabilities & Equity | $1.3B | $1.4B | $1.4B | $1.8B | $1.8B |
| — Key Metrics — | |||||
| Total Debt | $631M | $643M | $763M | $1.1B | $1.1B |
| Net Debt | $560M | $481M | $476M | $954M | $997M |
| Total Investments | $44M | $102M | $94M | $106M | $4M |